HIGHLIGHTS
- who: Hiroyuki Suzuki from the Osaka University, Japan have published the research work: Case Report: Exacerbation of varices following atezolizumab plus bevacizumab treatment of hepatocellular carcinoma: A case series and literature review, in the Journal: (JOURNAL)
- what: The authors evaluated 105 patients with advanced HCC who received AB treatment between January 2020 and December 2021 at the institute (Kurume University Hospital and Iwamoto Internal Medicine Clinic). It has been reported that once gastrointestinal bleeding occurs, combination treatment continuation will be difficult in most cases for the following reasons: rapid deterioration in liver function, rapid growth . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.